LabCentral today announced that Deck Bio and ReTrax Therapeutics were awarded LabCentral Golden Tickets sponsored by Bristol Myers Squibb (BMS). The prizes were awarded on October 8, 2025, during the ...
Unions call for employee status and minimum wage for 25 lakh workers while activists urge a ban on centralised kitchens and ...
Bristol Myers Squibb is pivoting from small-molecule drugs to mRNA and gene therapies. Click here to read more about BMY ...
Q3 2025 Earnings Call Transcript October 23, 2025 Visteon Corporation misses on earnings expectations. Reported EPS is $ EPS, ...
Patients with chemorefractory metastatic colorectal cancer derive no overall survival benefit from giving anti-EGFR ...
New initiative aims to build capacity in high-prevalence areas to increase screening and prevention of hemoglobinopathies NORTHAMPTON, MA / ACCESS Newswire / October 17, 2025 / PATH has launched a gro ...
Stop guessing and start optimizing. DCIM provides real-time visibility into power, cooling, space, and asset health to reduce ...
Disclaimer: This column is merely a guiding voice and provides advice and suggestions on education and careers. The writer is ...
Bristol Myers Squibb's acquisition of Orbital Therapeutics includes OTX-201, a next-gen CAR T-cell therapy, and a proprietary ...
Construction is underway at Bristol Motor Speedway as crews get ready for one of the region’s biggest holiday traditions.This ...
Johnny Cheng, currently CFO of HUTCHMED, has been named acting CEO following the departure of Dr Weiguo Su due to health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback